Evidence map›Paper›PMID 24828500›Full record

ArticleThe Journal of biological chemistry2014

Allosteric regulation of the human and mouse deoxyribonucleotide triphosphohydrolase sterile α-motif/histidine-aspartate domain-containing protein 1 (SAMHD1).

Cristina Miazzi, Paola Ferraro, Giovanna Pontarin, Chiara Rampazzo, Peter Reichard, Vera Bianchi

Open access · hybridAbstract readComparative Study
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Prime Editing in Dividing and Quiescent Cells.International journal of molecular sciences · 2025
    Review
  4. SAMHD1 restricts the deoxyguanosine triphosphate pool contributing to telomere stability in telomerase-positive cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2023
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. The structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Cristina MiazziFrom the Department of Biology, University of Padova, 35131 Padova, Italy.
Paola FerraroFrom the Department of Biology, University of Padova, 35131 Padova, Italy.
Giovanna PontarinFrom the Department of Biology, University of Padova, 35131 Padova, Italy.
Chiara RampazzoFrom the Department of Biology, University of Padova, 35131 Padova, Italy.
Peter ReichardFrom the Department of Biology, University of Padova, 35131 Padova, Italy.
Vera BianchiFrom the Department of Biology, University of Padova, 35131 Padova, Italy vbianchi@bio.unipd.it.
University of Padua · IT

Funding

Telethon GGP09019
6 · The paper itself

Abstract

The deoxyribonucleotide triphosphohydrolase SAMHD1 restricts lentiviral infection by depleting the dNTPs required for viral DNA synthesis. In cultured human fibroblasts SAMHD1 is expressed maximally during quiescence preventing accumulation of dNTPs outside S phase. siRNA silencing of SAMHD1 increases dNTP pools, stops cycling human cells in G1, and blocks DNA replication. Surprisingly, knock-out of the mouse gene does not affect the well being of the animals. dNTPs are both substrates and allosteric effectors for SAMHD1. In the crystal structure each subunit of the homotetrameric protein contains one substrate-binding site and two nonidentical effector-binding sites, site 1 binding dGTP, site 2 dGTP or dATP. Here we compare allosteric properties of pure recombinant human and mouse SAMHD1. Both enzymes are activated 3-4-fold by allosteric effectors. We propose that in quiescent cells where SAMHD1 is maximally expressed GTP binds to site 1 with very high affinity, stabilizing site 2 of the tetrameric structure. Any canonical dNTP can bind to site 2 and activate SAMHD1, but in cells only dATP or dTTP are present at sufficient concentrations. The apparent Km for dATP at site 2 is ∼10 μm for mouse and 1 μm for human SAMHD1, for dTTP the corresponding values are 50 and 2 μm. Tetrameric SAMHD1 is activated for the hydrolysis of any dNTP only after binding of a dNTP to site 2. The lower Km constants for human SAMHD1 induce activation at lower cellular concentrations of dNTPs thereby limiting the size of dNTP pools more efficiently in quiescent human cells.

Indexed as

Allosteric RegulationAnimalsBinding SitesDeoxyadenine NucleotidesDeoxyguanine NucleotidesGene Expression Regulation, EnzymologicHumansHydrolysisKineticsMiceModels, MolecularMonomeric GTP-Binding ProteinsNucleotidasesSAM Domain and HD Domain-Containing Protein 12'-deoxyadenosine triphosphateDeoxyadenine NucleotidesDeoxyguanine Nucleotidesdeoxyguanosine triphosphateMonomeric GTP-Binding ProteinsNucleotidasesSAM Domain and HD Domain-Containing Protein 1SAMHD1 protein, humanSamhd1 protein, mouseAllosteric RegulationDNA EnzymeDNA ReplicationEnzyme KineticsEnzyme Mechanism

Identifiers

PMID24828500
PMCPMC4140260
OpenAlexW2130309413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.